ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Nephrology

Top Nephrology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL SILVERMAN M.D.

Nephrology

11,131

$657K

473
413 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $100

JULIUS RESNIK M.D.

Nephrology

10,177

$629K

611
548 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

GEORGE BESCAK D.O.

Nephrology

10,159

$985K

569
476 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $100

MAHMOUD EL KHATIB M.D.

Nephrology

9,296

$703K

241
133 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $100

RAUL HERNANDEZ M.D.

Nephrology

8,207

$653K

358
268 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $100

ROMEO MICLAT M.D.

Nephrology

7,430

$699K

484
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $100

MAHYAR TAHBAZ DO

Nephrology

6,867

$1.01M

543
314 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$146
Average prescription price

Avg: $100

GEORGE VARGHESE MD

Nephrology

6,649

$265K

653
434 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $100

JEFFREY AUSTEN MD

Nephrology

6,204

$754K

339
233 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 24%

$121
Average prescription price

Avg: $100

FRANK COSENTINO D.O.

Nephrology

6,191

$535K

539
420 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $100

WILLIAM WILMER M.D.

Nephrology

5,562

$381K

499
374 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $100

JOSHUA AUGUSTINE MD

Nephrology

5,474

$430K

329
82 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $100

KENNETH LEMPERT MD

Nephrology

5,346

$449K

254
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$84
Average prescription price

Avg: $100

JOHN MACLAURIN DO

Nephrology

5,266

$509K

296
157 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $100

CHRISTOPHER ENOCH D.O.

Nephrology

5,243

$518K

460
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $100

DAVID IMLER D.O.

Nephrology

5,187

$504K

306
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $100

GLENN BRYANT M.D.

Nephrology

5,132

$436K

386
296 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$85
Average prescription price

Avg: $100

MICHAEL GANZ M.D.

Nephrology

4,809

$249K

253
97 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $100

SANJU VARGHESE MD

Nephrology

4,551

$376K

360
247 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $100

PIUS KURIAN MD

Nephrology

4,449

$444K

292
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$100
Average prescription price

Avg: $100

NORMAN MOSER D.O.

Nephrology

4,427

$497K

259
172 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

GREGORY STEPHENS M.D.

Nephrology

4,293

$413K

270
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$96
Average prescription price

Avg: $100

STEPHANIE LADSON-WOFFORD M.D.

Nephrology

3,866

$469K

235
164 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 24%

$121
Average prescription price

Avg: $100

GAUTHAM MOGILISHETTY M.D.

Nephrology

3,771

$374K

226
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $100

KATHLEEN PADGITT M.D.

Nephrology

3,721

$295K

323
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank